SNPX: Synaptogenix, Inc. Stock

by  •  • Comments Off on SNPX: Synaptogenix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.92
Enterprise Value ($M) -15.39
Book Value ($M) 13.12
Book Value / Share 9.68
Price / Book 0.30
NCAV ($M) 12.57
NCAV / Share 9.27
Price / NCAV 0.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 65.36
Current Ratio 65.36

Balance Sheet (mrq) ($M)
Current Assets 22.28
Assets 22.83
Liabilities 9.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G/A Intracoastal Capital, Llc 4.99 33.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 191 14,300 1.34
2025-02-03 815 21,278 3.83
2025-01-31 118 468 25.21
2025-01-30 724 9,104 7.95

(click for more detail)

Similar Companies
SLS – SELLAS Life Sciences Group, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc. SNSE – Sensei Biotherapeutics, Inc.
SNTI – Senti Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io